Gabriel Bsteh

Gabriel Bsteh

UNVERIFIED PROFILE

Are you Gabriel Bsteh?   Register this Author

Register author
Gabriel Bsteh

Gabriel Bsteh

Publications by authors named "Gabriel Bsteh"

Are you Gabriel Bsteh?   Register this Author

27Publications

577Reads

20Profile Views

Commentary on "Lymphocytic colitis in the setting of teriflunomide use for relapsing multiple sclerosis".

Mult Scler 2020 Feb 7:1352458520904546. Epub 2020 Feb 7.

Department of Neurology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458520904546DOI Listing
February 2020

Pregnancy and multiple sclerosis in the DMT era: A cohort study in Western Austria.

Mult Scler 2020 Jan 3;26(1):69-78. Epub 2018 Dec 3.

Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458518816614DOI Listing
January 2020

Commentary to "Letter to the editor: To treat or not to treat study - Comparative group inclusion considerations" for multiple sclerosis and related disorders.

Mult Scler Relat Disord 2020 Jan 31;40:101975. Epub 2020 Jan 31.

Department of Neurology, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2020.101975DOI Listing
January 2020

To treat or not to treat: Sequential individualized treatment evaluation in relapsing multiple sclerosis.

Mult Scler Relat Disord 2019 Dec 23;39:101908. Epub 2019 Dec 23.

Department of Neurology, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2019.101908DOI Listing
December 2019

Serum hepcidin levels in multiple sclerosis.

Mult Scler J Exp Transl Clin 2019 Oct-Dec;5(4):2055217319885984. Epub 2019 Nov 4.

Department of Neurology, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2055217319885984DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831977PMC
November 2019

Impairment of odor discrimination and identification is associated with disability progression and gray matter atrophy of the olfactory system in MS.

Mult Scler 2019 Mar 21:1352458519838205. Epub 2019 Mar 21.

Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria/Neuroimaging Research Core Facility, Medical University of Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458519838205DOI Listing
March 2019

Change of olfactory function as a marker of inflammatory activity and disability progression in MS.

Mult Scler 2019 02 29;25(2):267-274. Epub 2017 Nov 29.

Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria/Department of Neurology, University Hospital Zurich, Zurich, Switzerland; University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458517745724DOI Listing
February 2019

Transient impairment of olfactory threshold in acute multiple sclerosis relapse.

Mult Scler Relat Disord 2018 Jul 26;23:74-77. Epub 2018 May 26.

Department of Neurology, Medical University of Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2018.05.006DOI Listing
July 2018

Smoking is not associated with higher prevalence of JC virus in MS patients.

Eur J Clin Microbiol Infect Dis 2018 May 8;37(5):907-910. Epub 2018 Feb 8.

Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10096-018-3204-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916978PMC
May 2018

Discontinuation of disease-modifying therapies in multiple sclerosis - Clinical outcome and prognostic factors.

Mult Scler 2017 Aug 20;23(9):1241-1248. Epub 2016 Oct 20.

Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458516675751DOI Listing
August 2017

Severe early natalizumab-associated PML in MS: Effective control of PML-IRIS with maraviroc.

Neurol Neuroimmunol Neuroinflamm 2017 Mar 8;4(2):e323. Epub 2017 Feb 8.

Department of Neurology (G.B., M.A., S.I., G.S., T.B.), Department of Neuroradiology (L.-M.W.), and Department of Psychiatry (G.S.-M.), Medical University of Innsbruck; and Department of Neurology (D.L., S.K.), Landeskrankenhaus Rankweil, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000323DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299628PMC
March 2017

Serum Cotinine Does Not Predict Neutralizing Antibodies Against Interferon Beta in an Austrian MS Cohort.

J Interferon Cytokine Res 2016 12 19;36(12):667-670. Epub 2016 Oct 19.

1 Innsbruck Medical University , Department of Neurology, Innsbruck, Austria .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/jir.2016.0054DOI Listing
December 2016

Rethinking the importance of paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis: They do matter.

Mult Scler Relat Disord 2016 Sep 27;9:150-4. Epub 2016 Jul 27.

Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2016.07.014DOI Listing
September 2016

NMDA receptor antibodies: A rare association in inflammatory demyelinating diseases.

Neurol Neuroimmunol Neuroinflamm 2015 Oct 13;2(5):e141. Epub 2015 Aug 13.

Clinical Department of Neurology (M. Ramberger, G.B., K.S., A.L., F.D., T.B., M. Reindl) and Department of Pediatrics I (K.R., M.B.), Medical University of Innsbruck, Austria; Institute of Neurology (R.H.), Medical University of Vienna, Austria; Pediatric Neurology (K.R.), Witten/Herdecke University, Children's Hospital Datteln, Datteln, Germany; Department of Neurology (F.A.-D.), Karl Landsteiner Institute for Neuroimmunological and Neurodegenerative Disorders, Sozialmedizinisches Zentrum Ost Donauspital, Vienna, Austria; and Neuroimmunology and Multiple Sclerosis Research (A.L.), Department of Neurology, University Hospital Zurich and University of Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000141DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537309PMC
October 2015